Ann: Azer-cel Accepted for Presentation at ASTCT Tandem Meetings, page-21

  1. 3,390 Posts.
    lightbulb Created with Sketch. 306
    Read it.

    I stand corrected now that I have reread the article, that they are expecting to recruit a further 40 patients for the upcoming trial, the first pt was a bowel cancer pt.

    Released 11th November:

    https://www.listcorp.com/asx/imu/imugene/news/imugene-expands-car-t-cell-and-oncolytic-virotherapy-trials-in-australia-and-the-us-3113916.html
    Last edited by Scottsmyname: 20/12/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.002(18.2%)
Mkt cap ! $97.07M
Open High Low Value Volume
1.2¢ 1.4¢ 1.1¢ $625.7K 50.56M

Buyers (Bids)

No. Vol. Price($)
20 5795292 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 3258567 9
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.